The innovative body-jet ® eco has been designed for the precise and gentle removal of small fat tissue volumes that may be used for subsequent autologous fat transfer. A pulsating water-jet combined with a tissue-sparing, defined vacuum allows harvesting intact and highly viable fat cells from the subcutaneous fat tissue in a gentle way.
The gentle water-jet technology helps to avoid side effects that may develop in the donor area as a result of a "dry", manual liposuction, as well as damages to the fat cells often resulting from a toohigh syringe vacuum and shear forces.
Harvesting autologous fat with the body-jet ® eco saves time and money. This effect becomes significant in the case of small fat tissue volumes from 20 cc.
The fat tissue harvested and collected in a sterile, closed system (body-jet ® eco and FillerCollector ® ) is highly viable, finely dispersed and excellently suited for immediate re-injection due to the optimum lobular size of approx. 0.9 mm. A further treatment of the aspirated tissue such as filtration or centrifugation is not necessary.
Compared to other methods, the results of water-jet assisted liposuction & lipofilling are predictable, as proven by a multitude of published clinical studies. When extracting fat cells the subcutaneous fat tissue, blood, lymph vessels and nerves are spared. The very high fat cell viability of approximately 90 % allows that up to 87 % of the grafted tissue volume is preserved and adheres to the recipient area. The success of the treatment is very well predictable according to numerous clinical studies. presenting first promising results on the treatment of osteoarthritis with lipoaspirate injections: "We injected adipose tissue into the thumb carpometacarpal joint in a pilot study. Average preoperative pain according to a VAS was 7.4 in action and 3.8 during rest. It was reduced considerably to 2.2 in action and 0 during rest after 1 month and to 2.4 and 0.8, respectively, 3 months after surgery. The reduction of pain in action was statistically significant 1 month after injection (p=0.042). Average grip strength was 78 % and pinch grip strength was 74 % in comparison to the healthy side preoperatively, 89 % and 80 % one month postoperatively and 93 % and 89 %, respectively, 3 months postoperatively. An average DASH score of 58 preoperative was reduced to 36 after 1 month and 33 after 3 months. The amelioration of hand function was statistically significant (p=0.042 and p=0.043). There were no side effects and all patients were satisfied. These preliminary results are promising. Adipose tissue injection seems to be an alternative to consider, especially as it does not exclude classical surgical options in cases of failure." *Handchir Mikrochir plast Chir 2014; 46(02): 108-112 Volume 7
• June 2014 "I got introduced to breast augmentation with autologous fat during the BEAULI Workshop in Berlin, Germany, in June 2009. At that time, this method was not recommended in South Korea, therefore it was a kind of "culture shock". However during the BEAULI Workshop, I observed the procedures and results carefully and came to the conclusion that this method was not only safe but also efficient. My method for breast augmentation with fat starts with the use of body-jet ® evo. The fat is harvested from the thigh or abdomen. After collection and filtering in the LipoCollector ® , the fat is simultaneously injected into the patient`s breast. This procedure is repeated 3 months later, if the patient requests larger augmentations. Due to the Asian skin type, which is tighter than of western women, most of my patients use the BRAVA system for pre-expansion of the breast tissue for about 3-4 weeks before the actual surgery day. The advantages of using the body-jet ® evo is simply amazing because my results are more constant and the survival rate of the grafted fat is much higher. There is the factor of time as well as the operations are faster. The risk of infections is much lower because there is no air contact. Also, from my observations and experience, my patients seem to be more comfortable during and after the surgery. I used this method for approximately 2,400 successful operations during 4 years. About 80 % of my patients are satisfied with their results. For the remaining 20 % I have contingency plans, which are a) repeat the fat grafting procedure, or b) switch to silicone implants. 
INTRODUCTION
Autologous fat as a filler has great advantages because it uses the patient`s own tissue, it is less expensive, and delivers the required quantity to the desired region, with long lasting results. TECHNIQUE
The procedure is carried out, • either under local anaesthesia with or without oral pre-medication, depending on the level of anxiety and the reaction to pain, • or under general anaesthesia. This is also recommended when fat grafting is associated with other procedures. On the donor site, local anaesthesia is provided by the water-jet. This is more efficient than the usual application of local anaesthesia. It is applied with adrenaline and lidocaine or even general anaesthesia, in order to obtain temporary vasoconstriction, and to limit haematoma. This is done with a 25 gauge needle at the cannula entry point into the skin, then with a cannula (1mm in diameter) after creation of an entry point with an 18 gauge needle. Marking: It always begins with accurate markings and drawings of the face in a sitting position in order to visualize the effect of gravity. The harvesting of adipose tissue is done by water-jet assisted lipoaspiration with the body-jet®eco, either under local anaesthesia or under general anaesthesia. Sterile closed loop collection, filtering, washing and concentration of the lipoaspirate is done with the FillerCollector ® which is connected to the body-jet ® eco. This provides a viable, evenly dispersed fat quantity within a short time (10 to 15 minutes for the first 100 cc of lipoaspirate).
For the face, the 3.5 mm Biofill ® cannula is used. Due to the water-jet capillary inside the Biofill ® cannula, the lobular size of the harvested fat cell clusters is 0.7 -0.9 mm which is the optimum size for the survival of the fat transplant in the recipient tissue. This technique allows simultaneous infiltration and aspiration via the same Biofill ® cannula. It is preferable that the sampling region should be one that is resistant to weight loss. No preparation of adipose tissue is required apart from decanting. The watery phase in the FillerCollector ® is drained automatically by the vacuum of the bodyjet ® eco. Thus, the obtained adipose tissue is fluid with a remaining serum content of 20 to 25 %, and can pass through the injection cannula smoothly and without damaging the adipocytes. The lipofilling into the face is more regular and reduces the risk of any lumps. Instruments used: • 1ml syringes, • BEAULI ® injection cannulas of 1.4 mm outer diameter/1.0 mm inner diameter, lateral long hole 3.4 mm or tip angular cut 65° (human med AG), • in special cases, intradermical 25 gauge needles, if possible 23 gauge needles. The technique is the same as recommended by Sydney Coleman 15 years ago, maximizing regeneration and revascularisation of the fat graft. • Start by making a tunnel with the injection cannula followed by depositing single adipose tissue particles in the tunnel while retracting the cannula. • Create multiple separate tunnels in many layers and always deposit single adipose tissue particles in the tunnels while retracting the cannula. • Join the tunnels. • Thus, the individual fat particles or micro fat droplets that are "seeded" into the recipient tissue, will be regenerated and revascularized. Working in 3 dimensions helps to • eliminate the risk of having larger adipose tissue particles between the vessels, so as to prevent necrosis of the central area. • avoid a major rise in intra-tissue pressure within the recipient area, and the compression of the vessels which could lead to ischemia and necrosis, and finally to the loss of the tissue graft. Quantity limits should be respected; grafting of too much volume will lead to a loss of part of the graft. Dressing is done at the end of the surgery with Steri-strips™ in order to maintain position of the treated areas while ensuring revascularisation of the grafts. CONCLUSION Like all techniques lipofilling to the face has its own rules and limits that must be known and respected, alone or together with other techniques for satisfactory results.
COMPOSITE BREAST AUGMENTATION

INTERVIEW WITH DR. C. A. SALZBERG, NEW YORK; USA
The new concept of breast augmentation using the core projection of implants covered with the natural look and feel of the patient`s own fat (Composite) has become popular.
In the following interview, Dr. C. Andrew Salzberg, M.D., Associate Professor in the Division of Plastic Surgery, New York Medical College, and Attending Mount Sinai Medical Center, New York, USA explains the method.
Dr. Salzberg what do you like about the method of combining implants with autologous fat for breast augmentation?
The ability to alter the shape and contour of the breast with both an implant and subcutaneous fat transfer at the same time allows the surgeon unparalleled capability to refine the beauty of the breast and the ability to place one's own tissue in exactly the needed areas of the breast.
What is the main advantage of combining implant and autologous fat?
Autologous fat is the natural filler. It allows for consistent and persistent correction of breast deformities and volume deficiencies.
What method do you apply for fat harvesting and lipofilling?
I use water-jet assisted liposuction and lipofilling.
What do you like about the water-jet method?
I enjoy the ease of use and effectiveness of the body-jet ® and the LipoCollector ® . The system is contained from suction to collection, filtering and up to reinjection. I also appreciate the preservation of the fat tissue by the water-jet technology and the ease of reinjection. With combining implants and water-jet assisted fat grafting, I get reliable results in a one stage procedure.
Can you give us some key technical points of the procedure?
I do a subpectoral implant placement followed by subcutaneous tissue transfer only into retro mammary and subcutaneous spaces. After the operation I recommend only light compression or none at all for immediate tissue healing.
What are your main applications of fat grafting with body-jet ® ?
I mainly use the body-jet ® for liposuction, fat grafting, breast augmentation, buttock augmentation and correction of soft tissue defects, lipofilling in the face and hands, and for the treatment of burn scars and chronic lower extremity wounds.
new injection cannulas
Hydrodissection is the key principle of a facelift concept called the Aqualift. "With Aqualift the water-jet technology combines minimal impact and collateral damage with powerful dissection. For example, using the mobilization force of the water-jet, the mandibular ligaments, that have to be dissected for a natural reposition of the facial structures, can be addressed with minimal risk of nerve irritation or damage. With this technique there is significantly less bleeding in comparison to the conventional technique of translumination. Besides the advantages of the tissue selective characteristics of the water-jet, the dissection takes place considerably faster thus reducing the overall procedure time. Another advantage for both the patient and the surgeon is, that the procedure does not require drainage of the operation site by redon drainages and can be performed as an outpatient procedure. Compliance and follow up are easier, when the patients do not suffer from severe bruising and swelling. Even for smokers there is minimized danger of healing complications because of less trauma due to the gentle water-jet dissection." * Presentation The authors "performed a pilot study using a novel stem cell therapy approach that was performed during one surgical procedure. It relies on abdominal lipoaspiration and processing of connective tissue to stromal vascular fraction (SVF) cells that typically contain relatively large amounts of mesenchymal stromal and stem cells. SVF cells are injected immediately to the target joint or to the connective tissue of the target joint. Since 2011, total of 1128 patients have been treated with SVF injections into 1 -4 joints (knees and hips) per patient. A total num-ber of 1769 joints were treated. Clinical scale evaluation including pain, non-steroid analgesic usage, limping, extent of joint movement and stiffness was used as measurement of the clinical effect. All patients were diagnosed with stage II-IV osteoarthritis using clinical examination and X-ray, in some cases MRI was also performed to monitor the changes before and after stem cell therapy. Results: After 12 months from SVF therapy, and clinical scale evaluation, 81% of patients hat at least 50% improvement of clinical disorders, and 47% of patients had at least 75% clinical improvement, respectively. Within 1-2 weeks from SVF therapy 72% of patients were off the non-steroid analgesics and most of them remained such for at least 12 months. No serious side effects, infection or cancer was associated with SVF cell therapy." In a study of the Department of Cell Biology of the Rostock University Medical Center the content and viability of adipose stem cells in adipose tissue harvested by water-jet assisted (WAL) liposuction (body-jet ® system), combined with the LipoCollector ® has been investigated. The study concludes that • cell population isolated from WAL-isolated adipose tissue contains a large number of highly viable adMSC (15 % of the processed lipoaspirate/PLA are plastic adherent and CD34-positive); • adMSC from WAL-isolated adipose tissue posses a specific mesenchymal differentiation capacity (tested were adipogenic and osteogenic differentiation). The total cell number (SVF) after flow cytometrie was 440,000 cells per g lipoaspirate, and the number of CD34+ (mesenchymal) cells was 183,000 cells per g lipoaspirate. After 24h incubation the total number of plastic adherent cells (SVF) was 140,000 cells per g lipoaspirate, and the number of plastic adherent CD34+ (mesenchymal) cells was 65,000 cells per g lipoaspirate.
Patients and Methods:
• Female patients ∅ age: 45.5 y (±12 y), n=6. • Adipose tissue from female abdomen, fundament and thigh. • Tumescence solution containing epinephrine, sodium-bicarbonate and lidocaine in 0.9 % saline. • Suction vacuum was 0.5 bar, 3.8 mm infiltration and aspiration cannula. During the 2013 ISPRES congress, T. Stasch presented a case series on the healing progress of chronic, non-healing lower-limb wounds in diabetic patients following perilesional autologous fat grafting. "The study included 16 diabetic patients (11 men and 5 women) with deep, non-healing chronic foot ulcerations that were previously unsuccessfully treated with traditional methods for a mean of 6 months (range, 2-33). In all patients, peripheral vascularperfusion had been optimized if possible. The ulcers were debrided and lipoaspirate was injected peri-lesionally." Methods: "The non-processed lipoaspirate (mean 7.7 +/-3.9 ml) was then transferred into the wounds using a closed system, with peri-lesional infiltration into the edges and base of the chronic wounds. The wound was then covered with a PVA foam and negative pressure applied (VAC-System) for 5 days. Thereafter the wounds were regularly assessed and measured and covered with Suprasorb H ® dressings until complete healing. Healing was defined as complete reepithelialisation of the wound. Wound sizes were measured and analysed using digital photography." Results: "Wound size after debridement averaged 4.8 +/-3.6 cm2. 13/16 wounds (81 %) of wounds healed completely within a mean of 10 weeks. In 2 patients with particularly deep ulcera, another session of lipofilling lead to complete wound healing after another 4 weeks. All patients were followed up for at least 4 months after wound healing which showed stable tissues in all." Discussion: "Chronic ulcers on the lower diabetic limb pose a particularly challenging situation with a high morbidity for the patient often associated with recurrent surgical debridements and eventually amputations in a compromised vascularized environment. This study shows the enormous effects of autologous fatgrafting on wound healing as a relatively easy to perform and well tolera- After a misdiagnosis in 2011 that resulted in life-changing serious complications, Catherine learned that she has lipoedema and in fact has had it for many years since early puberty. She unsuccessfully sought answers from many specialists in the US discovering that "knowledge about lipoedema is almost non-existent in the US at this time." However, there are 17 million women with unrecognized and misdiagnosed lipoedema in the US alone, with over 3 million in both Germany and the UK. In her search for experts she went to Europe and found, interviewed and filmed for a documentary about lipoedema, the most experienced plastic surgeons and their operation procedures in Germany, The study findings demonstrate that water-assisted liposuction is an almost painless procedure that produces less tissue trauma than traditional liposuction." "After water-assisted liposuction with the bodyjet ® , the lipocytes in the aspirate were shown to be predominantly intact: "In 28 of the 30 investigated lipoaspirates (patients), the lipocytes were found to be predominantly (>70 %) intact." In this study, "forty-one consecutive patients were treated with WAL (Body-Jet; Human Med) for mildto-moderate body contouring. Patients were given local anesthesia (standardized tumescent solutions) during all three phases of the surgery. During the latter two phases, irrigation of tumescent solution was accompanied simultaneously by suction aspiration. Fat harvesting was accomplished by collecting and separating the aspirated adipose tissue in a sterile container LipoCollector ® ), without need for washing or centrifugation. Fat grafting by microdroplet technique was performed within two hours of collection. Fat aliquots from five randomly-selected patients were assessed with a trypan blue dye exclusion test within one hour and again six to eight hours after collection." Results: "A total of 37 females and four males underwent WAL in this series; average body mass index (BMI) was 25.5. Among the 41 patients, 166 areas involving twelve anatomic sites were treated. Patients were divided into two groups based on the volume of treatment: Group 1 contained 19 patients with small-volume WAL and Group 2 had 22 cases of moderate-volume WAL. All patients experienced uneventful recovery periods with minimal side effects and no significant complications. Although large volumes of tumescent solution were required during the three phases of the technique, the total volume of infiltration almost equaled the final volume of aspiration. The average infiltration-toaspiration ratio was 1.1 to 1.0 in all cases over both groups. Lidocaine dosage averaged 10.5mg/kg in Group 1 and 20.0mg/kg in Group 2." "Trypan blue dye exclusion testing indicated that about 90 % of adipocytes expelled the dye after one hour of extraction (meaning 90 % cell viability), while an estimated 10 % of cells per patient were observed to be free of dye six to eight hours after removal." The author concludes that the "amount of instilled tumescent fluid, lidocaine dosage, and aspiration volumes appeared to be safe, with minimal blood loss in small and moderate volume liposuction cases".
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